American Express Crushes Earnings with Revamped Platinum Card Success
American Express exceeds Q3 expectations with $421B in transactions as new $895 Platinum card doubles account acquisitions, proving premium credit card demand remains strong.
Feed↓
/ What's going on?
Filter:
Artiva Biotherapeutics Stock Soars: Wedbush Raises Price Target to $23 on Breakthrough RA Treatment
Wedbush upgrades Artiva Biotherapeutics price target to $23 citing FDA Fast Track for AlloNK therapy targeting refractory rheumatoid arthritis with potential 2026 pivotal trial.
FDA Fast-Tracks First Vaping Cessation Treatment for Cytisinicline
Achieve Life Sciences receives FDA's National Priority Voucher for cytisinicline, potentially the first approved treatment to help people quit vaping and e-cigarettes.
Revolution Medicines Receives FDA Priority Voucher for Cancer Drug Daraxonrasib
Revolution Medicines awarded FDA National Priority Voucher for daraxonrasib (RMC-6236), a breakthrough RAS inhibitor targeting pancreatic and lung cancer in Phase 3 trials.
XORTX Acquires Promising Kidney Disease Treatment from Vectus Biosystems
XORTX Therapeutics announces $3M acquisition of VB4-P5, a novel anti-fibrotic compound targeting kidney disease, expanding its renal therapy pipeline.
Deutsche Bank Upgrades Intuitive Machines: Space Stock Set to Soar
Deutsche Bank analyst upgrades Intuitive Machines to Buy with $18 price target, citing "strong catalysts" and discount to space peers. Major contracts could drive gains.